
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GILD | Buenos Aires | ARS | Delayed | |
GILD | NASDAQ | USD | Real-time | |
GILD | Mexico | MXN | Delayed | |
GGILD | Milan | EUR | Real-time | |
GILD | TradeGate | EUR | Delayed | |
GILD | Frankfurt | EUR | Delayed | |
GILD | Xetra | EUR | Delayed | |
GILDCL | Santiago | CLP | Delayed | |
GILD | Santiago | USD | Delayed | |
GILD | Vienna | EUR | Delayed |
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Name | Age | Since | Title |
---|---|---|---|
Eugene R. Schiff | - | - | Member of the Scientific Advisory Board |
Jacqueline K. Barton | 68 | 1989 | Independent Director |
Paul E. Klotman | - | - | Member of the Scientific Advisory Board |
John W. Mellors | 83 | - | Member of the Scientific Advisory Board |
Francis V. Chisari | - | - | Member of the Scientific Advisory Board |
Sandra J. Horning | 72 | 2020 | Independent Director |
Mark C. Genovese | - | - | Member of Scientific Advisory Board |
Daniel P. O'Day | 57 | 2019 | Chairman & CEO |
Harish M. Manwani | 68 | 2018 | Independent Director |
Malcolm MacCoss | 73 | - | Member of Scientific Advisory Board |
Nezam H. Afdhal | 64 | - | Member of Scientific Advisory Board |
Robert A. Harrington | - | - | Member of the Scientific Advisory Board |
Kevin E. Lofton | 66 | 2009 | Lead Independent Director |
Paul Berg | 94 | 1998 | Member of Scientific Advisory Board |
Kelly A. Kramer | 53 | 2016 | Independent Director |
Eric J. Topol | 67 | - | Member of Scientific Advisory Board |
Robert T. Schooley | - | - | Member of the Scientific Advisory Board |
Kenneth C. Anderson | 70 | - | Member of the Scientific Advisory Board |
Brian J. Druker | 66 | - | Member of the Scientific Advisory Board |
Joel R. Huff | - | - | Chairperson of Scientific Advisory Board |
Javier J. Rodriguez | 50 | 2020 | Independent Director |
Jeffrey A. Bluestone | 68 | 2020 | Independent Director |
Anthony Welters | 66 | 2020 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review